Japan is the second major market where Kisunla has received approval Kisunla was first approved in the United States in July 2024 INDIANAPOLIS, Sept. 24, 2024 /PRNewswire/ — The Ministry of Health, Labour and Welfare Japan has approved Kisunla™ (donanemab-azbt, 350 mg/20 mL every four…
Month: September 2024
NEW YORK, Sept. 24, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Sprinklr, Inc. (“Sprinklr” or the “Company”) (NYSE: CXM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sprinklr investors who were adversely…
NEW YORK, Sept. 24, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Sage Therapeutics, Inc. (“Sage Therapeutics” or the “Company”) (NASDAQ: SAGE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sage Therapeutics…
NEW YORK, Sept. 24, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Verve Therapeutics, Inc. (“Verve Therapeutics” or the “Company”) (NASDAQ: VERV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Verve Therapeutics…
NEW YORK, Sept. 24, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Five Below, Inc. (“FIVE” or the “Company”) (NASDAQ: FIVE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of FIVE investors who were adversely…
NEW YORK, Sept. 24, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Arbor Realty Trust, Inc. (“ABR” or the “Company”) (NYSE: ABR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ABR investors who were adversely…
NEW YORK, Sept. 24, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Endava plc (“Endava” or the “Company”) (NYSE: DAVA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Endava investors who were adversely affected by…
NEW YORK, Sept. 24, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DexCom investors who were adversely…
NEW YORK, Sept. 24, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in DXC Technology Company (“DXC Technology” or the “Company”) (NYSE: DXC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DXC Technology investors who…
NEW YORK, Sept. 24, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Lululemon Athletica Inc. (“Lululemon” or the “Company”) (NASDAQ: LULU) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lululemon investors who were…